Results 241 to 250 of about 254,610 (274)
Evidence‐based management strategies for endocrine complications after pituitary adenoma surgery
Based on the PIPOST (Population, Intervention, Professional, Outcome, Setting, and Type of Evidence) framework, evidence‐based medicine questions were developed, and a top‐down search was conducted according to the 6S model of the evidence pyramid. The literature sources were best practices, guidelines, expert consensuses, systematic reviews, meta ...
Xiaoju Miao+7 more
wiley +1 more source
Epidemiology of Thyroid Cancer in Tuscany (Central Italy) 2013-2017: Not Just Overdiagnosis. [PDF]
Capezzone M+31 more
europepmc +1 more source
A retrospective study of 17,995 patients investigating the location and recurrence of papillary thyroid cancer. [PDF]
Qi P+10 more
europepmc +1 more source
Impact of ablation dose in the treatment of thyroid cancer with I-131
Cholid Badri, Dharma Gayo, Suryo Seto
openalex +2 more sources
What's New? While net cancer survival has markedly improved in Canada over the past decades, it is unclear whether all Canadians have benefited equally due to a paucity of data disaggregated by individual‐level equity stratifiers. Using data linkage of the census with the cancer registry, the authors provide nationally representative estimates of ...
Talía Malagón+4 more
wiley +1 more source
Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Study. [PDF]
Radi S+5 more
europepmc +1 more source
What's New? Because of widespread use and resistance to degradation, per‐ and polyfluoroalkyl substances (PFAS) are ubiquitous in the environment. For young children, owing in part to crawling and hand‐to‐mouth behaviors, PFAS exposure is unique. Here, the authors investigated the risk of childhood leukemia in relation to PFAS found in settled dust ...
Catherine Metayer+6 more
wiley +1 more source
Causal role of immune cells in thyroid cancer: a two-sample Mendelian randomization study. [PDF]
Wang S+5 more
europepmc +1 more source
The transcription factor RIP140 regulates interferon γ signaling in breast cancer
What's New? Interferon γ (IFNγ) is a key player in breast cancer, with the potential to induce apoptosis and to shift tumors into a dormant state. However, it also may promote carcinogenesis and angiogenesis. In this study, transcriptomic analysis identified the transcription factor RIP140 as a key regulator of IFNγ signaling in breast cancer.
Stéphan Jalaguier+9 more
wiley +1 more source